# Inflammation and Tissue Healing Process


## Key Takeaways

- The inflammatory phase is the initial and critical component of tissue healing, not a separate prelude; its quality dictates the subsequent repair trajectory, with excessive or prolonged inflammation leading to dysregulated healing and scarring.
- Macrophages exhibit a phenotypic continuum from M1-like pro-inflammatory to M2-like pro-repair states, with the transition from M1 dominance to M2 dominance being essential for resolving destructive inflammation and advancing to the proliferative phase.
- Platelets are crucial throughout all healing phases, initiating hemostasis via clot formation and releasing growth factors that support inflammation, proliferation, and remodeling.
- Mesenchymal stem cells (MSCs) play a coordinating role in repair by recruiting host cells, secreting growth factors and matrix proteins, and modulating immune responses, contributing significantly to connective tissue regeneration.
- Healing by primary intention (apposed surgical incisions) involves minimal granulation tissue and scarring, whereas healing by secondary intention (open wounds) requires granulation tissue formation, contraction, and epithelialization, often resulting in more pronounced inflammation and longer remodeling.
- Factors such as perfusion, infection, foreign material, and species-specific responses (e.g., exuberant granulation tissue in horses) significantly modify healing outcomes, necessitating tailored clinical assessment and intervention.

---

This article explains the cellular and molecular events that connect inflammation to tissue repair across mammalian and avian species. It is written for veterinary students who have completed basic immunology and pathology coursework and now need a working framework for interpreting biopsy findings, planning wound management, and understanding why some injuries heal with regeneration while others end in fibrosis. The discussion covers the classic phases of healing, the immune cells that drive each phase, and the mechanisms that determine whether repair restores normal architecture or produces scar tissue. Chronic inflammation and organ-specific healing responses are excluded.

The inflammatory response is not a separate event that precedes healing. It is the first phase of healing, and its quality sets the trajectory for everything that follows. Excessive, prolonged, or inadequately resolved inflammation is a major cause of dysregulated wound healing, and limiting that excess reduces scarring. Conversely, insufficient inflammation delays debridement and leaves the wound vulnerable to infection. The clinician's task is to recognize where a given patient sits on that spectrum and to intervene only when the response has moved outside its useful range.

## At a Glance

| Parameter | Clinical relevance |
|---|---|
| Healing phases | Inflammation, proliferation, remodelling, overlap in time and space instead of discrete stages |
| Inflammatory phase duration | Roughly days 0 to 5 in acute wounds, longer with infection, foreign material, or poor perfusion |
| Key inflammatory cells | Neutrophils dominate early, then macrophages, lymphocytes appear later and modulate resolution |
| Macrophage polarisation | M1-like pro-inflammatory and M2-like pro-repair phenotypes exist as a continuum, not a strict dichotomy |
| Platelet contribution | Platelet growth factors support all three healing phases, also clot formation |
| Mesenchymal stem cells | Endogenous MSCs coordinate repair by recruiting host cells and secreting growth factors and matrix proteins |
| Healing by primary intention | Clean, apposed surgical incisions heal with minimal granulation tissue and scar |
| Healing by secondary intention | Open wounds fill by granulation, contraction, and epithelialisation, more inflammation and longer remodelling |
| Foreign body response | Biomaterials trigger protein adsorption, acute and chronic inflammation, giant cell formation, and fibrous encapsulation |

## The Inflammatory Phase of Healing

### Vascular and Cellular Events

Tissue injury disrupts blood vessels, exposing subendothelial collagen and activating platelets. Platelets aggregate and degranulate, releasing growth factors that support the inflammatory, proliferative, and remodelling phases of repair. The same platelet-derived signals that initiate hemostasis also recruit neutrophils and monocytes to the injury site. Vasoactive mediators, including histamine and prostaglandins, cause arteriolar dilation and increased venular permeability, producing the rubor, calor, tumor, and dolor of acute inflammation. Plasma proteins, including fibrinogen and complement, extravasate into the wound bed and form a provisional matrix.

Neutrophils arrive within hours, drawn by chemotactic signals from complement fragments, platelet products, and bacterial peptides. They phagocytose debris and bacteria and release proteolytic enzymes that degrade damaged matrix. Their lifespan in tissue is short, and they undergo apoptosis once their task is complete. Persistent neutrophilic infiltration beyond the first several days suggests ongoing contamination, foreign material, or ischemia.

### Macrophage Polarisation and the M1 to M2 Continuum

Monocytes enter the wound after neutrophils and differentiate into macrophages. These cells dominate the later inflammatory phase and bridge into proliferation. Classically activated M1-like macrophages secrete pro-inflammatory cytokines including IL-1β, IL-6, IL-12, IL-23, and TNF-α, and they drive tissue injury and microbial killing. Alternatively activated M2-like macrophages secrete IL-10, TGF-β, and chemokines including CCL1, CCL2, CCL17, CCL18, and CCL22, and they promote wound healing and tissue remodelling.

The M1 and M2 designations originated from experimental models and are useful as conceptual anchors, but in clinical tissue the distinction is a continuum. Individual macrophages shift phenotype in response to local signals, and mixed profiles are common, particularly in infectious disease. A wound that fails to transition from M1-dominant to M2-dominant activity tends to stall in a state of destructive inflammation. This failure underlies many chronic non-healing wounds.

## The Proliferative Phase

### Granulation Tissue Formation

As inflammation resolves, macrophages secrete growth factors that stimulate fibroblast proliferation and angiogenesis. Fibroblasts deposit type III collagen and proteoglycans, while new capillaries sprout from adjacent venules. The resulting granulation tissue is grossly red, friable, and moist. Its formation is essential for healing by secondary intention, where the wound must fill from the base upward.

Mesenchymal stem cells participate throughout this phase. Endogenous MSCs coordinate the repair response by recruiting other host cells and secreting growth factors and matrix proteins. They also regulate immune responses and inflammation, and their capacity to differentiate into bone, cartilage, tendon, and fat makes them central to connective tissue repair. Exogenous MSC preparations have been used to stimulate stalled healing in chronic wounds, although translation from animal models to clinical protocols remains challenging.

### Epithelialisation and Contraction

Keratinocytes at the wound margin proliferate and migrate across the granulation bed. Migration requires a moist surface and a viable underlying matrix. In loose-skinned species, including dogs and cats, myofibroblasts in the wound margins contract and pull the wound edges together, reducing the area that must epithelialise. In tight-skinned species, including horses and humans, contraction contributes less and epithelialisation must cover a larger defect.

## The Remodelling Phase

Remodelling begins weeks after injury and continues for months. Type III collagen is gradually replaced by type I collagen, and the initially disorganised matrix becomes oriented along lines of tensile stress. Cellularity and vascularity decline as the scar matures. The resulting tissue is less strong than the original, typically reaching only a fraction of the tensile strength of uninjured skin. Wound strength increases slowly and remains reduced for months to years.

The balance between collagen synthesis and degradation is controlled by matrix metalloproteinases and their tissue inhibitors. Disruption of this balance produces either excessive scarring or chronic wound breakdown. The immune system continues to modulate remodelling, and strategies that limit inflammation during this phase reduce scarring.

## Healing by Primary and Secondary Intention

Primary intention healing occurs when wound edges are apposed, as in a clean surgical incision. The inflammatory phase is brief, granulation tissue is minimal, and the scar is narrow. Secondary intention healing occurs when a wound is left open, either because tissue loss prevents apposition or because contamination makes closure unsafe. The inflammatory phase is more pronounced, granulation tissue fills the defect, and contraction and epithelialisation complete the repair. Tertiary intention, or delayed primary closure, combines both approaches: the wound is left open during the inflammatory phase and surgically closed once contamination is controlled.

## Factors That Modify Healing

Local factors dominate the outcome. Perfusion determines oxygen and nutrient delivery, and ischemia prolongs every phase. Infection consumes the inflammatory response and delays transition to proliferation. Foreign material, including suture, dirt, and implanted biomaterials, triggers a persistent inflammatory response. Biomaterials in particular elicit a predictable sequence of protein adsorption, acute inflammation, chronic inflammation, foreign body giant cell formation, and fibrous capsule formation. The physical and chemical features of the material influence the severity of each phase, but predicting the host response from surface characteriztics alone remains unreliable.

Systemic factors include age, nutritional status, and endocrine disease. Glucocorticoids suppress the inflammatory phase and delay healing. Diabetes impairs neutrophil function and angiogenesis. Protein and vitamin deficiencies reduce collagen synthesis. Species differences matter as well: horses are prone to exuberant granulation tissue, while rabbits and rodents heal rapidly with less scarring.

## Clinical Assessment of Healing

The first decision in managing any wound is determining whether healing will proceed by primary or secondary intention. Primary intention applies to clean, surgically apposed wounds with minimal tissue loss. Secondary intention is required for wounds with substantial tissue deficit, contamination, or infection. The distinction matters because it changes the entire monitoring protocol and the expectations for each phase.

Assessment begins with the three-dimensional characterization of the wound. Record the dimensions, depth, and involvement of underlying structures. Document the presence of foreign material, necrotic tissue, or exudate. The age of the wound and the mechanism of injury inform the likelihood of bacterial contamination. A wound sustained outdoors, in a barn, or in contact with fecal material carries a higher bioburden than a surgically created wound. The vascularity of the wound bed determines the capacity for granulation tissue formation. Wounds over poorly vascularised structures such as tendon, bone, or cartilage heal more slowly and require different management.

Serial assessment is the foundation of monitoring. Photographs taken at each bandage change provide an objective record of progress. Measure the wound at the same location each time, using the same method. Tracings onto sterile film or calibrated grids allow calculation of surface area. Depth should be measured with a sterile probe or ruler. These measurements detect stalled healing early, when intervention is still straightforward.

## Monitoring Parameters and Their Interpretation

The clinician must distinguish normal inflammatory changes from complications. During the first 48 to 72 hours, mild erythema, edema, and serous discharge are expected. Pain should decrease progressively after the initial inflammatory peak. A wound that becomes more painful, more swollen, or more exudative after day three requires investigation.

| Parameter | Normal Finding | Abnormal Finding | Likely Interpretation |
|---|---|---|---|
| Exudate color and odour | Serous or serosanguinous, minimal odour | Purulent, malodorous, grey or green | Bacterial infection, foreign body |
| Wound bed color | Red, granular, uniform | Pale, yellow, black, or dull | Poor perfusion, necrosis, biofilm |
| Wound margin | Pink, well-defined, advancing | Erythematous, macerated, rolled | Excessive inflammation, infection |
| Pain on palpation | Decreasing after day 3 | Increasing after day 3 | Infection, dehiscence, ischemia |
| Exudate volume | Decreasing | Increasing | Infection, seroma, fistula |
| Epithelialisation rate | Visible new epithelium at wound edge | No epithelial advance in 7 days | Stalled healing, infection, malnutrition |

Body temperature and systemic parameters should be assessed at each recheck. Fever, lethargy, or inappetence in a patient with a healing wound raises the suspicion of spreading infection. Regional lymphadenopathy is expected in the early inflammatory phase but should resolve as healing progresses.

## Interventions That Change the Healing Trajectory

Debridement is the single most important intervention in wound management. Necrotic tissue supports bacterial growth and physically obstructs the inflammatory and proliferative phases. The clinician must decide between surgical debridement, enzymatic debridement, or autolytic debridement based on the wound bed and the patient's status. Surgical debridement is fastest and most complete but requires anesthesia and can damage viable tissue if performed aggressively. Enzymatic agents are useful for wounds where surgical debridement is not feasible, but they require a moist environment and can be slow. Autolytic debridement relies on the wound's own phagocytic activity and is appropriate only for clean wounds with low bacterial burden.

Lavage reduces bacterial load and removes debris. The choice of solution matters. Sterile isotonic saline is the safest option. Antiseptic solutions such as chlorhexidine or povidone-iodine are effective but can be cytotoxic to healing tissue at high concentrations. The clinician must balance antimicrobial effect against tissue toxicity. Pressures of 8 to 15 psi are generally cited as effective for bacterial removal without driving contamination deeper into tissue. A 19-gauge needle on a 35 mL syringe delivers approximately this range, whereas bulb syringes deliver insufficient pressure.

Bandaging decisions depend on the phase of healing. The inflammatory phase requires a dressing that absorbs exudate and maintains a moist environment. The proliferative phase benefits from dressings that protect granulation tissue and support epithelialisation. The remodelling phase may require pressure bandages to reduce scarring and contracture. Each dressing change is an opportunity to reassess the wound and adjust the plan.

## Species and Production System Considerations

The healing process is broadly conserved across mammals, but practical management differs substantially by species. Horses are prone to exuberant granulation tissue, particularly on the distal limbs. This requires more aggressive wound bed management and often the use of topical corticosteroids to suppress excessive proliferation. Cats heal more slowly than dogs and are more prone to wound contraction and skin tension. Their thin skin and tendency to self-traumatise wounds complicate bandaging.

In production animals, the economic and welfare context changes the decision framework. A dairy cow with a distal limb wound may be managed differently from a companion animal because of the demands of locomotion, milk production, and the production environment. Wounds in pastured animals are exposed to flies, mud, and fecal contamination. Fly control becomes a therapeutic priority in warm months. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address wound care and infection control in the context of animal health and welfare, and these standards inform management decisions in production settings.

Patient status modifies the healing trajectory. Hypoproteinaemia delays granulation tissue formation because protein is required for matrix synthesis. Anemia reduces oxygen delivery to the wound bed. Endocrine disease such as diabetes mellitus or hyperadrenocorticism impairs the inflammatory response and slows healing. Nutritional status is a modifiable factor that the clinician should address directly. Vitamin C is required for collagen synthesis in most species, and zinc deficiency impairs epithelialisation.

## Documentation and Communication

The medical record must capture the wound assessment in a structured format. Record the date, wound dimensions, wound bed appearance, exudate characteriztics, and the presence of any complications. Photographs should be labelled with the patient identification and date. The record should state the planned intervention and the rationale for that intervention. This allows the next clinician to assess whether the wound is progressing as expected.

Client communication should set realistic expectations about the duration of healing. Secondary intention healing in a large wound takes weeks to months. The client must understand the commitment to bandage changes, activity restriction, and recheck examinations. Written instructions reduce the risk of misunderstanding. The [AVMA professional practice resources](https://www.avma.org/resources-tools) provide guidance on client communication and medical record keeping that supports consistent documentation standards.

The [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) provides species-specific guidance on wound management and healing expectations. Where the evidence base is limited, the clinician should acknowledge this uncertainty and base decisions on the principles of wound physiology instead of on unverified claims. The [Davis-Thompson Foundation veterinary pathology resources](https://www.davisthompsonfoundation.org/) offer case material that illustrates the gross and histologic appearance of healing wounds and their complications, which supports accurate assessment in practice.

## When Healing Fails

A wound that fails to progress through the expected phases requires systematic investigation. The differential list includes infection, foreign body, ischemia, malnutrition, and systemic disease. Bacterial culture and sensitivity testing should be performed when infection is suspected. Imaging may be required to identify foreign material or osteomyelitis. Biopsy of the wound bed can distinguish between stalled healing and neoplasia, particularly in chronic wounds.

The inflammatory phase can become self-perpetuating. Excessive or persistent inflammation impairs the transition to the proliferative phase. This is the mechanism by which chronic wounds become stuck. The [review of immune regulation in skin wound healing](https://pubmed.ncbi.nlm.nih.gov/29984112/) describes how excess inflammation is a major cause of dysregulated healing and how controlling the immune response is a target for therapeutic intervention. The clinician should therefore consider whether the wound is being over-treated. Excessive lavage, overly aggressive debridement, or inappropriate antiseptic use can maintain inflammation and prevent healing.

The [literature on macrophage polarisation in infectious disease](https://pubmed.ncbi.nlm.nih.gov/29921749/) illustrates that the balance between pro-inflammatory and reparative macrophage phenotypes is a continuum instead of a binary switch. In clinical terms, this means that the goal is not to eliminate inflammation but to modulate it. The wound needs enough inflammation to clear debris and pathogens, but not so much that the proliferative phase is delayed.

Adjunctive therapies may support healing in selected cases. [Platelet-rich plasma preparations](https://pubmed.ncbi.nlm.nih.gov/33096812/) have been investigated as a source of growth factors that support the healing cascade, and [mesenchymal stem cell therapy](https://pubmed.ncbi.nlm.nih.gov/23197761/) has been used to stimulate stalled healing. The evidence base for these modalities is evolving, and the clinician should evaluate each case individually. [Low-level light therapy](https://pubmed.ncbi.nlm.nih.gov/20011653/) shows a biphasic dose response, where lower energy levels may be more effective than higher levels, but the optimal parameters remain uncertain. These therapies are adjuncts, not replacements, for sound wound management.

## Recognized Complications and Early Detection

Healing fails through predictable pathways, and each has identifiable early markers. Excessive inflammation is the most common derailment. Persistent neutrophilic infiltration beyond the first 48 to 72 hours, progressive edema, and exudate that shifts from serosanguinous to purulent indicate that the inflammatory phase is not resolving. Serial wound scoring, including color, odour, exudate volume, and surrounding skin temperature, detects this trajectory before overt necrosis develops. [Immune regulation of skin wound healing](https://pubmed.ncbi.nlm.nih.gov/29984112/) identifies excess inflammation as a major cause of dysregulated healing, and limiting that excess reduces scarring.

Foreign body reaction represents a distinct failure mode, particularly after biomaterial implantation or when suture material, plant material, or debris remains in the wound bed. The reaction proceeds through protein adsorption, acute and chronic inflammation, foreign body giant cell formation, and fibrous capsule formation. Early detection relies on persistent swelling or sinus tract formation at the implant site, with imaging or surgical exploration confirming the diagnosis. [The pathology of the foreign body reaction against biomaterials](https://pubmed.ncbi.nlm.nih.gov/27813288/) notes that predicting the response to a specific material from its surface properties alone remains unreliable, so clinical vigilance is the primary detection tool.

Ischemia and tension cause wound edge necrosis that presents as progressive discolouration of the wound margin within the first 48 hours. Dehiscence typically follows between days 5 and 10, when suture holding strength in edematous or infected tissue is lowest. Seroma or hematoma formation under a closed wound elevates the skin flap and creates dead space that predisposes to infection. Ultrasonography or needle aspiration discriminates fluid accumulation from solid swelling.

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Persistent purulent exudate beyond day 3 | Bacterial infection or retained foreign material | Cytology for intracellular bacteria, aerobic culture, imaging for radiopaque debris |
| Sinus tract or draining fistula at implant site | Foreign body reaction | Surgical exploration, histopathology of excised tract |
| Wound edge pallor progressing to black | Ischemia from excessive tension or compromised vascular supply | Fluorescein perfusion assessment, wound margin biopsy |
| Sudden serosanguinous discharge after day 5 | Dehiscence or deep infection | Gentle probing of wound depth, ultrasound for fluid pocket |
| Non-progressive wound with pale, dry bed | Stalled proliferative phase | Biopsy for bacterial load and tissue viability |

## Common Errors and Corrective Actions

Students and early-career clinicians most often mistake the normal inflammatory appearance for infection. Redness, heat, and serous exudate in the first 72 hours are physiologic. The discriminating feature is trend: normal inflammation plateaus and improves, while infection progresses. Serial assessment with a standardized wound score prevents this error.

A second frequent error is aggressive debridement of viable granulation tissue. Granulation tissue is fragile and bleeds easily, which can be mistaken for unhealthy tissue. The distinction rests on color and texture. Healthy granulation is bright red with a finely cobblestoned surface. Pale, gelatinous, or grey granulation indicates hypoperfusion or heavy bacterial colonisation and warrants biopsy instead of further debridement.

Inappropriate antimicrobial selection follows from sampling error. Surface swabs culture contaminants, not tissue pathogens. Deep tissue biopsy or aspiration of the advancing edge provides meaningful culture results. [Davis-Thompson Foundation veterinary pathology resources](https://www.davisthompsonfoundation.org/) offer case material that demonstrates the histologic distinction between surface colonisation and invasive infection, a useful study aid for this common error.

A third error is premature closure of wounds with marginal viability. The decision to close primarily requires that the wound bed support a tension-free closure with adequate perfusion. When uncertain, delayed primary closure at day 3 to 5 allows the inflammatory phase to declare itself and converts an uncertain wound into a predictable one.

## Limitations of Current Evidence

The evidence base for healing interventions carries significant translational limitations. [Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020](https://pubmed.ncbi.nlm.nih.gov/33096812/) observes that recommendations derived from in vitro and animal studies frequently fail to predict human clinical outcomes, and the same caution applies across species. Platelet dosing, leukocyte content, and activation method vary widely between preparations, and no standardized formulation exists.

Macrophage polarisation research illustrates a related problem. The M1/M2 dichotomy is well characterized in rodent models, but [the role of human macrophage polarisation in inflammation during infectious diseases](https://pubmed.ncbi.nlm.nih.gov/29921749/) describes the human situation as a continuum with mixed profiles instead of discrete states. Veterinary species likely sit somewhere between these extremes, and extrapolation from either model requires caution.

Low-level light therapy demonstrates a biphasic dose response, where lower fluences stimulate repair and higher fluences inhibit it. [Biphasic dose response in low level light therapy](https://pubmed.ncbi.nlm.nih.gov/20011653/) documents this Arndt-Schulz relationship, but the optimal parameters for each species, tissue type, and wound stage remain undefined. Expert opinion differs on whether light therapy belongs in standard wound care protocols or only in refractory cases.

Mesenchymal stem cell therapy shows promise in animal models and reported clinical cases, particularly for chronic wounds. [The role of mesenchymal stem cells in wound repair](https://pubmed.ncbi.nlm.nih.gov/23197761/) describes their capacity to recruit host cells and secrete growth factors, but delivery methods, cell dosing, and timing of administration lack standardization. The evidence supports cautious optimizm, not routine clinical adoption.

## Referral and Escalation Criteria

Referral to a specialist surgeon or wound care service is warranted when the wound involves critical structures, when serial debridement fails to produce a viable bed, or when the defect exceeds the clinician's reconstructive capacity. Early referral is preferable to delayed referral after repeated failed interventions.

Laboratory involvement is indicated for persistent non-healing wounds, suspected neoplasia, or unusual pathogens. Histopathology distinguishes neoplasia from exuberant granulation tissue and identifies fungal or atypical bacterial infections. Microbiology with antimicrobial susceptibility testing guides therapy when empirical treatment has failed.

Regulatory reporting obligations vary by jurisdiction and production system. Wounds associated with notifiable diseases, suspected foreign animal diseases, or food safety concerns may trigger mandatory reporting. [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) define international reporting obligations for listed diseases, while [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional obligations in the United States. Clinicians must know the requirements for their region and species. [MSD Veterinary Manual professional content](https://www.msdvetmanual.com/) offers species-specific guidance on wound complications and their management thresholds.

## Frequently Asked Questions

### How do I distinguish normal inflammation from infection during the inflammatory phase of healing?

Normal inflammation follows a predictable timeline with localized heat, swelling, and pain that peaks within 24 to 72 hours and gradually subsides. Infection interrupts this trajectory. Look for progressive erythema beyond the wound margin, purulent or malodorous exudate, delayed granulation tissue formation beyond day five, and systemic signs such as fever or leukocytosis. Serial assessment matters more than a single examination. If the inflammatory phase extends beyond four to five days without progression to proliferation, suspect bacterial contamination or foreign material. Cytology of exudate can differentiate degenerate neutrophils with intracellular bacteria from the mixed inflammatory population expected in normal healing. Culture and sensitivity testing should accompany any decision to escalate antimicrobial therapy.

### What should I do when advanced wound care products are unavailable or cost-prohibitive?

Standard wound management principles remain effective without commercial products. Lavage with sterile isotonic fluids, debridement of devitalised tissue, and moisture-retentive dressings form the foundation of care. When commercial dressings are unavailable, alternatives include saline-moistened gauze for autolytic debridement and petroleum-impregnated gauze to prevent adherence. Honey-impregnated dressings can be substituted with medical-grade honey applied to a non-adherent contact layer. The evidence base for many advanced products, including platelet-rich plasma, derives largely from in vitro and animal studies that translate inconsistently to clinical practice, as noted in [reviews of platelet-rich plasma performance](https://pubmed.ncbi.nlm.nih.gov/33096812/). Prioritize consistent wound hygiene, appropriate debridement, and infection control over product selection. Document the resources used and the rationale for any substitutions in the medical record.

### How does the healing trajectory differ between cats and dogs?

Cats heal more slowly than dogs and rely less on contraction and more on epithelialisation for wound closure. Feline skin has a thinner dermis and less robust vascular supply, making flaps and grafts more precarious. Cats also show a higher incidence of inappropriate grooming behavior that disrupts sutures and dressings. The inflammatory phase in cats may be more prolonged, and exuberant granulation tissue is less common than in dogs. Feline fibroblasts produce less collagen and respond differently to growth factors, which may explain delayed closure in chronic wounds. Analgesic and anti-inflammatory drug choices differ between species, and this affects the inflammatory phase. Consult species-specific references such as the [MSD Veterinary Manual](https://www.msdvetmanual.com/) for drug selection and dosing guidance.

### What documentation is required for wound care cases in general practice?

Record the initial wound description including location, dimensions, depth, tissue types present, and estimated age. Document each treatment with the products used, the patient's response, and any complications. Serial photography with a scale marker provides objective evidence of progression. Note the client's compliance with home care instructions and any barriers to care. For wounds involving bite injuries or suspected non-accidental injury, documentation becomes legally significant. The [AVMA practice resources](https://www.avma.org/resources-tools) offer guidance on medical record standards. Include a wound diagram or description that allows a colleague to assess progression without relying on memory. Record the rationale for each intervention, particularly when deviating from standard protocols, and document client communication about prognosis and costs.

### How should I explain delayed healing to a frustrated client?

Use concrete language that connects visible signs to underlying biology. Explain that inflammation is the first stage of repair, not a sign of failure, and that certain conditions such as diabetes, malnutrition, or ongoing mechanical stress slow the process. Show the client serial photographs to demonstrate subtle progress they may not perceive day to day. Be honest about uncertainty: some wounds heal unpredictably despite appropriate care. The immune system's role in coordinating repair is complex, and excessive inflammation can itself impair healing, as described in [reviews of immune regulation in skin wound healing](https://pubmed.ncbi.nlm.nih.gov/29984112/). Offer a specific timeline for reassessment and define what improvement should look like. If cost is a concern, discuss which interventions are essential and which can be deferred without compromising the outcome.

### When should I refer a wound case to a specialist or advanced facility?

Refer when the wound involves exposed bone, joint, tendon, or major neurovascular structures, or when the defect exceeds what primary closure or second intention healing can reasonably achieve. Refer also when healing stalls despite appropriate management for two weeks, when there is evidence of osteomyelitis, or when the wound requires reconstructive surgery beyond your comfort level. Systemic illness, suspected sepsis, or wounds involving the thoracic, abdominal, or cranial cavities warrant immediate referral. The [Davis-Thompson Foundation pathology resources](https://www.davisthompsonfoundation.org/) can support biopsy interpretation when neoplasia or unusual pathology is suspected. Before referral, stabilize the patient, control hemorrhage, and cover the wound with a sterile dressing. Provide the receiving clinician with a complete history including wound age, prior treatments, and serial photographs.

## Related Clinical & Scientific Guides

* [Hypersensitivity Reactions: Types and Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/hypersensitivity-reactions-types-and-mechanisms)
* [Therapeutic Decision-Making for Respiratory Infections in Cattle](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-making-respiratory-infections-cattle)
* [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary)


## References and Further Reading

- [Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.](https://pubmed.ncbi.nlm.nih.gov/33096812/). 2020.
- [Concise review: role of mesenchymal stem cells in wound repair.](https://pubmed.ncbi.nlm.nih.gov/23197761/). 2012.
- [Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.](https://pubmed.ncbi.nlm.nih.gov/29984112/). 2018.
- [The pathology of the foreign body reaction against biomaterials.](https://pubmed.ncbi.nlm.nih.gov/27813288/). 2017.
- [Role of Human Macrophage Polarization in Inflammation during Infectious Diseases.](https://pubmed.ncbi.nlm.nih.gov/29921749/). 2018.
- [Biphasic dose response in low level light therapy.](https://pubmed.ncbi.nlm.nih.gov/20011653/). 2009.
- [Davis-Thompson Foundation Veterinary Pathology Resources](https://www.davisthompsonfoundation.org/). Davis-Thompson Foundation.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.

## Related Articles

- [Necropsy Tissue Collection and Histopathology Submission](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/necropsy-tissue-collection-and-histopathology-submission)
- [Acute Inflammation: Vascular and Cellular Events](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/acute-inflammation-vascular-and-cellular-events)
- [Chronic Inflammation: Causes and Morphologic Features](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/chronic-inflammation-causes-and-morphologic-features)
- [Therapeutic Decision Frameworks for Veterinary Inflammation](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-frameworks-veterinary-inflammation)
- [Adaptive Immunity: B Cell and T Cell Responses](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/adaptive-immunity-b-cell-and-t-cell-responses)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.